Reductions in body weight and sleep apnea severity in morbidly obese subjects – Which factors contribute to improvements in lung function and blood gases?

Anne Marie Gabrielsen (Skien, Norway), Anne Marie Gabrielsen, Jøran Hjelmesæth, May Brit Lund, Jan Magnus Fredheim, Sverre Lehmann, Dag Hofsø

Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Session: To treat or not to treat, and how? Sleep-disordered breathing I
Session type: Thematic Poster Session
Number: 2408
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Anne Marie Gabrielsen (Skien, Norway), Anne Marie Gabrielsen, Jøran Hjelmesæth, May Brit Lund, Jan Magnus Fredheim, Sverre Lehmann, Dag Hofsø. Reductions in body weight and sleep apnea severity in morbidly obese subjects – Which factors contribute to improvements in lung function and blood gases?. Eur Respir J 2015; 46: Suppl. 59, 2408

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
An electronic nose distinguishes the exhaled breath of obese patients with obstructive sleep apnoea (OSA) from subjects with a similar body mass index and without OSA
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014

The role of compliance with positive airway pressure use on blood pressure in patients with obstructive sleep apnea: Is longer use a key-factor?
Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine
Year: 2015


Relationship between echocardiographic assessment and plasma endothelin-1 levels in obese patients with or without obstructive sleep apnea
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015

Impaired control of gait in patients with severe obstructive sleep apnea is reversed by continuous positive airway pressure treatment
Source: International Congress 2016 – From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease
Year: 2016

Can we use the oxygen desaturation index alone to reliably diagnose obstructive sleep apnoea in obese patients?
Source: International Congress 2016 – Clinical presentation, daytime symptoms, and screening of obstructive sleep apnoea
Year: 2016

Effect of continuous positive airway pressure on blood pressure and the metabolic profile of women with obstructive sleep apnoea. A randomized-controlled trial
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016



Frequency and predictors of obesity hypoventilation syndrome in morbidly obese (BMI ≥40) patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013


Impacts of long-term CPAP therapy on fatty liver in male OSA patients with abdominal obesity
Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions
Year: 2014

Comparison of peri-pharyngeal muscle recruitment during upper airway obstruction in patients with OSA and healthy subjects during wakefulness and sleep
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016

Sleep disordered breathing in patients with cardiovascular comorbidities hospitalized for pulmonary disease
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015


Pulmonary function tests (PFT) and sleep disordered breathing (SDB) in morbidly obese children and adults
Source: International Congress 2016 – Latest advances in paediatric sleep medicine
Year: 2016

Management of eucapnic obese patients with sleep disordered breathing (SDB)
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013


Severity of sleep apnea and daytime hypoxemia do not significantly contribute to endothelial dysfunction in morbidly obese subjects
Source: Annual Congress 2010 - Sleep apnoea: insights from basic and clinical research
Year: 2010


Anthropometric markers of adiposity and visceral adiposity index (VAI) in patients with OSA
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013


Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients
Source: Eur Respir J 2009; 34: 694
Year: 2009



The effect of CPAP on blood pressure in patients with OSAS and resistant hypertension followed 1 year
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015

Effects of alveolar hypoventilation on nighttime plasma glucose in obese patients
Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing
Year: 2014

Upper airway stimulation in OSA patients increases airway size in a dose-response manner
Source: Annual Congress 2013 –Back to basics: the upper airway and physiology in sleep disordered breathing
Year: 2013


Continuous positive airway pressure therapy for obstructive sleep apnoea: Do patients who request to have a copy of their letters have better compliance?
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015


Obstructive sleep apnea contribution to blood antioxidant status of excess body mass index persons
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008